Article

timesofisrael.comtimesofisrael.com on 2023-09-05 14:11

Israel’s Pluri wins NIH contract for drug that could save lives in nuclear event

Company aims for FDA approval so that its novel cell therapy for radiation sickness can be eligible for US Strategic National Stockpile

Related news